Thu, Nov. 19, 4:59 PM
- Monsanto (NYSE:MON) execs say they are hopeful that Sunday’s presidential election vote in Argentina will lead to an overhaul of agricultural policies that have been blamed for reduced production and exports from the country that is a major producer of corn and soybeans.
- Both presidential candidates say they plan to scrap crop export taxes of 23% on corn and 35% on soybeans, a change that likely would be welcomed by farmers who have protested for years over the taxes that have caused many to hoard production rather than pay up.
- For MON, Argentina is an important growth market that could help it reach a target for higher earnings over the next four years, and CEO Hugh Grant has said ending the tariffs would incentivize sowing more acres.
Wed, Nov. 18, 2:23 PM
- Syngenta (SYT -3.7%) and other major players in the seeds and crop chemicals industry are in active discussions about potential tie-ups, Financial Times cites Chairman Michel Demare as saying in an interview.
- Conversations among the leading companies in the sector were "extremely active... "We are all convinced that [the sector] will look quite different in six months," Demare says.
- The comments come after Monsanto (MON +1.4%), which withdrew a bid to take over SYT earlier this year, said yesterday it was discussing whether to acquire or merge with major rivals in the seed and agrochemical industries.
Tue, Nov. 17, 2:32 PM
- Monsanto (MON -0.8%) top execs are discussing whether it should try to acquire agrochemical rivals, including another potential run at Syngenta (SYT +6.8%), MON President Brett Begemann says.
- The internal discussions, ongoing since MON abandoned its $46B offer for SYT in August, include weighing the benefits of bidding for rivals such as Bayer CropScience (OTCPK:BAYRY +1.1%), Reuters reports.
- MON expects its profit growth will reach 20%/year, and says it does not need a big acquisition to achieve its previously reported goal of doubling earnings to more than $10/share by 2019, Begemann also says.
- Earlier: Syngenta pops on news of another Monsanto approach
Tue, Nov. 17, 11:27 AM
Thu, Nov. 12, 7:57 AM
- The European Food Safety Authority says glyphosate, the active ingredient in Monsanto's (NYSE:MON) Roundup weedkiller, is unlikely to cause cancer in humans, but it proposes new controls on any residues in food.
- EFSA advises EU policymakers and its conclusion will be used to help decide whether to extend the current approval period for glyphosate, which ends on Dec. 31.
- Environmental groups have been calling for a ban after the World Health Organization said in March that glyphosate was "probably carcinogenic to humans."
Tue, Nov. 10, 8:05 AM
- Monsanto (NYSE:MON) updates its 2016 financial forecast, saying it expects FY 2016 adjusted EPS of $5.10-$5.60 to reflect additional restructuring charges, vs. analyst consensus expectations of $5.31; on an as-reported basis, EPS is projected at $4.00-$4.66, down from $4.44-$5.01 it forecast just last month..
- MON says its restructuring actions, combined with cost savings initiatives, should generate up to $200M of savings, bringing total estimated savings to $500M by the end of FY 2018.
- MON also continues to project free cash flow of $1.6B-$1.8B for FY 2016.
Thu, Nov. 5, 4:13 PM
- DuPont (DD +0.8%) is in discussions with Syngenta (SYT +6.3%) and Dow Chemical (DOW +0.4%) about potential major agriculture deals, Dow Jones reports.
- DD is said to be discussing potential combinations involving its ag division with SYT and DOW, as deal talk has gathered steam since Monsanto (MON -1%) abandoned its effort to acquire SYT in August; MON instead could face the threat of much-enlarged competitors if its rivals end up combining and it strikes no combination of its own.
- U.S. farm income is on pace to hit its lowest level in nearly a decade, pressuring profits in the global market for GMO seeds and chemicals to kill weeds and insects.
Tue, Nov. 3, 1:11 PM
- Deere (DE -0.4%) agrees to acquire Monsanto’s (MON +2.3%) Precision Planting equipment unit for an undisclosed sum, as it employs its strategy to boost farmer efficiency and productivity with technology.
- The deal allows nearly real-time data connections between certain John Deere farm equipment and Climate FieldView farming software programs.
- Reuters reports the news was met with skepticism by some farmers who have used Precision Planting's computer hardware and software tools to help them plant seeds in ways that will be most productive for boosting yields.
- This is DE's third precision agriculture deal in the past five weeks; yesterday, DE agreed to buy Monosem, the European leader in precision planter manufacturing, and nearly a month ago it announced a joint venture to further develop a cloud software platform developed by DN2K for agricultural retailers and other consultants.
Wed, Oct. 28, 12:41 PM
- A Monsanto (MON +0.8%) research center in France reportedly suffered heavy fire damage in a suspected arson attack earlier today.
- The fire is said to have been ignited from two different places at the site, where ~10 people work and which specializes in maize research.
- MON is a frequent target of criticism in France over concerns about genetically modified crops it has developed, and speculation is that the attack could be related.
Wed, Oct. 28, 10:49 AM
- Monsanto (MON +1%) hopes to double its sales in Mexico over the next five years, depending in part on whether permits for the cultivation of commercial-scale GMO corn are approved in the country, a Latin American official at the company tells Reuters.
- Mexico is in the midst of a fierce debate about whether to allow the cultivation of genetically modified corn, and a final decision could be resolved soon in the courts.
- In Mexico, 70% of MON's ~$400M sales are comprised of corn seeds that have been technologically altered.
Fri, Oct. 23, 6:12 PM
- The USDA approves Monsanto's (NYSE:MON) new genetically modified type of corn, MON 87411, after its review concluded it posed no significant threat to agricultural crops, other plants or the environment.
- MON developed the product to protect plants against corn rootworms that can damage roots and drag down grain yields and be tolerant to the glyphosate herbicide.
- The USDA's move is just one step in the multiyear process of commercializing genetically engineered seed traits; assessments are still needed by the U.S. FDA and EPA as well as regulators in other countries.
- MON hopes for a full commercial launch of its SmartStax PRO, a line of products featuring MON 87411 maize, by the end of the decade pending regulatory approvals.
Thu, Oct. 22, 5:33 PM
- Dow Chemical (NYSE:DOW) said today it would consider selling its farm business, and analysts tout DuPont (NYSE:DD) and Monsanto (NYSE:MON) as potential buyers, Reuters reports.
- "A different owner might be able to boost profitability immediately," says SunTrust's James Sheehan, who estimates selling the business could net Dow proceeds of ~$15B.
- Buying Dow's farm business would give DuPont the scale to compete with bigger players, especially in the crop protection market, and DuPont's global market share would jump to ~16% after a deal, says Mawer Investment portfolio manager Grayson Witcher.
- MON is looking for acquisitions after its failed bid for Syngenta, but Dow Agrosciences is only half the size of Syngenta and its seed business lags far behind.
Wed, Oct. 21, 2:19 PM
- Syngenta (SYT +6.4%) will continue to review its seed portfolio and look for deal opportunities but does not plan to engage Monsanto (MON +0.7%) on takeover talks, Chairman Michel Demaré tells Dow Jones in an interview following the sudden resignation of CEO Mike Mack.
- MON's proposal was financially risk and too low, Demaré says, and its rejection was "a unanimous decision" by SYT's board.
- SYT will be proactive in looking for openings to make its own acquisitions or seek to buy pieces spun off if rivals combine, Demaré says.
- Mack's exit did not arise from a difference over the company's strategy or its rejection of MON's takeover offer, the CEO adds.
Wed, Oct. 21, 9:54 AM
- Monsanto (MON +0.2%) asks California environmental officials to withdraw a plan to list glyphosate as a cause of cancer, saying the state is not considering valid scientific evidence; glyphosate is the main ingredient in the company's Roundup herbicide as well as many other herbicides.
- Listing glyphosate as a cancer cause "has the potential to deny farmers and public agencies the use of this highly effective herbicide," MON said in a public filing. "Global regulatory authorities... agree that glyphosate is not carcinogenic."
- State officials say its actions were required after the WHO's cancer research committee in March classified glyphosate as a probable human carcinogen.
Thu, Oct. 15, 6:58 PM
- U.S. personal injury law firms are gathering plaintiffs for what they say could be "mass tort" actions against Monsanto (NYSE:MON) that claim the company's Roundup herbicide has caused cancer in farm workers and others exposed to the chemical, Reuters reports.
- The latest lawsuit, filed yesterday in Delaware by three law firms representing three plaintiffs, is similar to others filed last month in New York and California accusing MON of knowing that glyphosate, the main ingredient in Roundup, was hazardous to human health.
- The litigation follows the World Health Organization's statement in March that there was sufficient evidence to classify glyphosate as "probably carcinogenic to humans."
Fri, Oct. 9, 5:35 PM
- Monsanto (NYSE:MON) says it has entered into a $3B accelerated share repurchase program, part of its $10B share repurchase authorization announced in June 2014.
- With the completion of its previous $6B accelerated share buyback, MON says it has repurchased more than 10% of its shares outstanding since June 2014.
- MON +0.8% AH.
Monsanto Co along with its subsidiaries provides agricultural products for farmers. Its seeds, biotechnology traits, herbicides and precision agriculture products provide farmers with solutions that improve productivity.
Other News & PR